Clinical Trial Update: Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement [Phase 2]

View source ↗

Summary

A Phase 2 trial testing the combination of encorafenib and binimetinib before surgery for melanoma with lymph node involvement has been terminated, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Melanoma
• Melanoma of Unknown Primary

Drugs mentioned

• Binimetinib (binimetinib)
• Encorafenib (encorafenib)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Melanoma of Unknown Primary, Metastatic Malignant Neoplasm in Lymph Node | Phase 2 | Status: TERMINATED | Results posted: 2025-06-08